Are you over 18 and want to see adult content?
More Annotations
A complete backup of www.thebirdwrites.com/2020/2/25/21152432/new-orleans-pelicans-los-angeles-lakers-gamethread-zion-williamson
Are you over 18 and want to see adult content?
A complete backup of news.mt.co.kr/mtview.php?no=2020030201040022413
Are you over 18 and want to see adult content?
A complete backup of www.bbc.co.uk/news/stories-51633897
Are you over 18 and want to see adult content?
A complete backup of www.hln.be/sport/voetbal/buitenlands-voetbal/premier-league/tottenham-verslikt-zich-op-eigen-veld-en-lijdt-
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of redingtongroup.com
Are you over 18 and want to see adult content?
A complete backup of topjunkcarremoval.com
Are you over 18 and want to see adult content?
A complete backup of voilanorbert.com
Are you over 18 and want to see adult content?
A complete backup of online-education.net
Are you over 18 and want to see adult content?
A complete backup of connected-intelligence.com
Are you over 18 and want to see adult content?
Text
MEDRXIV.ORG
medRxiv.org - the preprint server for Health Sciences. Advanced Search. Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should THERAPEUTIC ANTICOAGULATION IN CRITICALLY ILL PATIENTS Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. Methods We conducted an open-label, adaptive, multiplatform, randomized, clinical trial. Patients with severe Covid-19, defined as the requirement for organ support with high flow nasal cannula, non THERAPEUTIC ANTICOAGULATION IN NON-CRITICALLY ILL PATIENTS Background Thrombo-inflammation may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic-dose anticoagulation may improve outcomes in non-critically ill patients hospitalized for Covid-19. Methods In an open-label adaptive multiplatform randomized controlled trial, non-critically ill patients hospitalized for Covid-19, defined by the absence of critical FDA-AUTHORIZED COVID-19 VACCINES ARE EFFECTIVE PER REAL Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively. Given the ongoing vaccine rollout to healthcare personnel and residents of long-term care facilities, CHARACTERIZING LONG COVID IN AN INTERNATIONAL COHORT: 728 Objective To characterize the symptom profile and time course in patients with Long COVID, along with the impact on daily life, work, and return to baseline health. Design International web-based survey of suspected and confirmed COVID-19 cases with illness lasting over 28 days and onset prior to June 2020. Setting Survey distribution via online COVID-19 support groups and social media EFFICACY ESTIMATES FOR VARIOUS COVID-19 VACCINES: WHAT WE E cacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports Julia Shapiro1, Natalie E. Dean1, Zachary J. Madewell1, Yang Yang1, M.Elizabeth Halloran2, 3, and Ira Longini1* 1Department of Biostatistics, University of Florida, Gainesville, FL, USA 2Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA GLUCOCORTICOIDS AND B CELL DEPLETING AGENTS SUBSTANTIALLY Methods We conducted a prospective assessment of mRNA-based vaccine immunogenicity in 133 adults with CIDs and 53 immunocompetent controls. Blood from participants over 18 years of age was collected before initial immunization and 1-2 weeks after the second immunization. Serum anti-SARS-CoV-2 spike (S) IgG + binding, neutralizing antibody titers, and circulating S-specific IMPACT OF THE CORONAVIRUS DISEASE (COVID-19) ON THE MENTAL1 Abstract Background: The novel coronavirus disease (COVID-19) is a serious global health problem that has negatively impacted the mental health of students. Methods: We conducted an online descriptive cross-sectional study among 273 undergraduate pharmacy students at the University of Zambia. A partial proportional odds regression model PHYSICAL, COGNITIVE AND MENTAL HEALTH IMPACTS OF COVID-19 2 Background The impact of COVID-19 on physical and mental health, and employment following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, observational study of adults discharged from hospital IMPACT OF VACCINATION ON SARS-COV-2 CASES IN THE COMMUNITY 1 Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey Emma Pritchard1,2, Philippa CMEDRXIV.ORG
medRxiv.org - the preprint server for Health Sciences. Advanced Search. Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should THERAPEUTIC ANTICOAGULATION IN CRITICALLY ILL PATIENTS Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. Methods We conducted an open-label, adaptive, multiplatform, randomized, clinical trial. Patients with severe Covid-19, defined as the requirement for organ support with high flow nasal cannula, non THERAPEUTIC ANTICOAGULATION IN NON-CRITICALLY ILL PATIENTS Background Thrombo-inflammation may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic-dose anticoagulation may improve outcomes in non-critically ill patients hospitalized for Covid-19. Methods In an open-label adaptive multiplatform randomized controlled trial, non-critically ill patients hospitalized for Covid-19, defined by the absence of critical FDA-AUTHORIZED COVID-19 VACCINES ARE EFFECTIVE PER REAL Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively. Given the ongoing vaccine rollout to healthcare personnel and residents of long-term care facilities, CHARACTERIZING LONG COVID IN AN INTERNATIONAL COHORT: 728 Objective To characterize the symptom profile and time course in patients with Long COVID, along with the impact on daily life, work, and return to baseline health. Design International web-based survey of suspected and confirmed COVID-19 cases with illness lasting over 28 days and onset prior to June 2020. Setting Survey distribution via online COVID-19 support groups and social media EFFICACY ESTIMATES FOR VARIOUS COVID-19 VACCINES: WHAT WE E cacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports Julia Shapiro1, Natalie E. Dean1, Zachary J. Madewell1, Yang Yang1, M.Elizabeth Halloran2, 3, and Ira Longini1* 1Department of Biostatistics, University of Florida, Gainesville, FL, USA 2Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA, USA GLUCOCORTICOIDS AND B CELL DEPLETING AGENTS SUBSTANTIALLY Methods We conducted a prospective assessment of mRNA-based vaccine immunogenicity in 133 adults with CIDs and 53 immunocompetent controls. Blood from participants over 18 years of age was collected before initial immunization and 1-2 weeks after the second immunization. Serum anti-SARS-CoV-2 spike (S) IgG + binding, neutralizing antibody titers, and circulating S-specific IMPACT OF THE CORONAVIRUS DISEASE (COVID-19) ON THE MENTAL1 Abstract Background: The novel coronavirus disease (COVID-19) is a serious global health problem that has negatively impacted the mental health of students. Methods: We conducted an online descriptive cross-sectional study among 273 undergraduate pharmacy students at the University of Zambia. A partial proportional odds regression model PHYSICAL, COGNITIVE AND MENTAL HEALTH IMPACTS OF COVID-19 2 Background The impact of COVID-19 on physical and mental health, and employment following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, observational study of adults discharged from hospital IMPACT OF VACCINATION ON SARS-COV-2 CASES IN THE COMMUNITY 1 Impact of vaccination on SARS-CoV-2 cases in the community: a population-based study using the UK’s COVID-19 Infection Survey Emma Pritchard1,2, Philippa C PREDICTORS OF SARS COV-2 INFECTION AMONG HEALTHCARE Aim We aimed to detect the risk factors for SARS-CoV-2 infection among healthcare workers (HCWs) in 2020, before vaccination era. Methods We surveyed the SARS-CoV-2 infection among the HCWs in a hospital by screening of antibody levels and detection of viral RNA by reverse transcription polymerase chain reaction (RT-PCR) between May 2020 toDecember 2020.
COLCHICINE IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19 Background Colchicine has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory actions. Methods In this randomised, controlled, open-label trial, several possible treatments were compared with usual care in patients hospitalised with COVID-19. Eligible and consenting adults were randomly allocated in a 1:1 ratio to either usual standard of care alone or usual OCCUPATION, WORK-RELATED CONTACT, AND SARS-COV-2 ANTI Methods We used data from a sub-cohort (n =3761) of adults (≥18) tested for SARS-CoV-2 anti-nucleocapsid antibodies between 01 February-28 April 2021 and responded to a questionnaire about work during the pandemic. Anti-nucleocapsid antibodies were used as a proxy of prior natural infection with COVID-19. We used logistic decomposition to estimate the total and direct effect of occupation EVIDENCE FOR INCREASED BREAKTHROUGH RATES OF SARS-COV-2 The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but A QUANTITATIVE RISK-BENEFIT ANALYSIS OF CHADOX1 NCOV-19 ChAdOx1 nCoV-19 is a vaccine against the COVID-19 infection that was granted a conditional marketing authorization by the European Commission in January 2021. However, following a report from the Pharmacovigilance Risk Assessment Committee (PRAC) of European Medicines Agency, which reported an association with thrombo-embolic events (TEE), in particular Disseminated EFFECTIVENESS OF BNT162B2 MRNA VACCINE AND CHADOX1 We estimated risk of death in vaccinated compared to unvaccinated COVID-19 cases. Cases vaccinated with 1 dose of BNT162b2 had 44% reduced risk of death, 55% with 1 dose of ChAdOx1, and 69% with 2 doses of BNT162b2. This is on top of the protection provided against becoming a case. ### Competing Interest Statement The authors have declared no competing interest. EMERGENCE OF N ANTIGEN SARS-COV-2 GENETIC VARIANTS SARS-CoV-2 genetic variants are emerging as a major threat to vaccination efforts worldwide as they may increase virus transmission rate and/or confer the ability to escape vaccine induced immunity with knock on effects on the level of herd immunity and vaccine efficacy respectively. These variants concern the Spike protein, which is encoded by the S gene, involved in virus entry into RAPID DETECTION OF NEUTRALIZING ANTIBODIES TO SARS-COV-2 Results Establishment of a modified hiVNT for qualitative detection of SARS-CoV-2 nAb Using the spikes of the prototype virus (D614G) and seven variants (B.1.1.7, B.1.351, P.1, ANTI-SPIKE PROTEIN ASSAYS TO DETERMINE POST-VACCINATION Background Reliable quantification of the antibody response to SARS-CoV-2 vaccination is highly relevant for identifying possible vaccine failure and estimating the time of protection. Therefore, we aimed to evaluate the performance of five different Anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies induced after a single dose of BNT162b2. SHUT AND RE-OPEN: THE ROLE OF SCHOOLS IN THE SPREAD OF We investigate the effect of school closure and subsequent reopening on the transmission of COVID-19, by considering Denmark, Norway, Sweden, and German states as case studies. By comparing the growth rates in daily hospitalisations or confirmed cases under different interventions, we provide evidence that the effect of school closure is visible as a reduction in the growth rateMEDRXIV.ORG
medRxiv.org - the preprint server for Health Sciences. Advanced Search. Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should THERAPEUTIC ANTICOAGULATION IN CRITICALLY ILL PATIENTS Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. Methods We conducted an open-label, adaptive, multiplatform, randomized, clinical trial. Patients with severe Covid-19, defined as the requirement for organ support with high flow nasal cannula, non FDA-AUTHORIZED COVID-19 VACCINES ARE EFFECTIVE PER REAL Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively. Given the ongoing vaccine rollout to healthcare personnel and residents of long-term care facilities, EVIDENCE FOR INCREASED BREAKTHROUGH RATES OF SARS-COV-2 The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but SPIKE PROTEIN ANTIBODIES MEDIATE THE APPARENT CORRELATION Objectives SARS-CoV-2 infection induces the formation of different antibodies. However, not all of which might prevent the virus from entering the cell, although their concentrations correlate with the titers of viral neutralization tests (NTs). Antibodies against the viral nucleocapsid (NC), e.g., can be classified as such. We aimed to prove the hypothesis that the apparent correlation CHARACTERIZATION OF THE SECOND WAVE OF COVID-19 IN INDIA Second Wave of COVID-19 in India 3 (a) Daily cases. (b) Daily deaths. Fig. 1: Comparison of COVID-19 spread in India with ve other severely-a ected countries. SHUT AND RE-OPEN: THE ROLE OF SCHOOLS IN THE SPREAD OF We investigate the effect of school closure and subsequent reopening on the transmission of COVID-19, by considering Denmark, Norway, Sweden, and German states as case studies. By comparing the growth rates in daily hospitalisations or confirmed cases under different interventions, we provide evidence that the effect of school closure is visible as a reduction in the growth rate REAL-WORLD EFFECTIVENESS OF AD26.COV2.S ADENOVIRAL VECTOR Clinical trials have demonstrated that multiple COVID-19 vaccines, including Ad26.COV2.S, are highly efficacious in reducing the risk ofsevere illness.
PHYSICAL, COGNITIVE AND MENTAL HEALTH IMPACTS OF COVID-19 2 Background The impact of COVID-19 on physical and mental health, and employment following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, observational study of adults discharged from hospital PREDICTED INFECTION RISK FOR AEROSOL TRANSMISSION OF SARS Currently, the respiratory route is seen as the most important transmission path for SARS-CoV-2. In this investigation, models of other researchers which had the aim of predicting an infection risk for exposed persons in a room through aerosols emitted by an infectious case-patient were extended. As a novelty – usually neglected – parameters or boundary conditions, namely the nonMEDRXIV.ORG
medRxiv.org - the preprint server for Health Sciences. Advanced Search. Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should THERAPEUTIC ANTICOAGULATION IN CRITICALLY ILL PATIENTS Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. Methods We conducted an open-label, adaptive, multiplatform, randomized, clinical trial. Patients with severe Covid-19, defined as the requirement for organ support with high flow nasal cannula, non FDA-AUTHORIZED COVID-19 VACCINES ARE EFFECTIVE PER REAL Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively. Given the ongoing vaccine rollout to healthcare personnel and residents of long-term care facilities, EVIDENCE FOR INCREASED BREAKTHROUGH RATES OF SARS-COV-2 The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but SPIKE PROTEIN ANTIBODIES MEDIATE THE APPARENT CORRELATION Objectives SARS-CoV-2 infection induces the formation of different antibodies. However, not all of which might prevent the virus from entering the cell, although their concentrations correlate with the titers of viral neutralization tests (NTs). Antibodies against the viral nucleocapsid (NC), e.g., can be classified as such. We aimed to prove the hypothesis that the apparent correlation CHARACTERIZATION OF THE SECOND WAVE OF COVID-19 IN INDIA Second Wave of COVID-19 in India 3 (a) Daily cases. (b) Daily deaths. Fig. 1: Comparison of COVID-19 spread in India with ve other severely-a ected countries. SHUT AND RE-OPEN: THE ROLE OF SCHOOLS IN THE SPREAD OF We investigate the effect of school closure and subsequent reopening on the transmission of COVID-19, by considering Denmark, Norway, Sweden, and German states as case studies. By comparing the growth rates in daily hospitalisations or confirmed cases under different interventions, we provide evidence that the effect of school closure is visible as a reduction in the growth rate REAL-WORLD EFFECTIVENESS OF AD26.COV2.S ADENOVIRAL VECTOR Clinical trials have demonstrated that multiple COVID-19 vaccines, including Ad26.COV2.S, are highly efficacious in reducing the risk ofsevere illness.
PHYSICAL, COGNITIVE AND MENTAL HEALTH IMPACTS OF COVID-19 2 Background The impact of COVID-19 on physical and mental health, and employment following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, observational study of adults discharged from hospital PREDICTED INFECTION RISK FOR AEROSOL TRANSMISSION OF SARS Currently, the respiratory route is seen as the most important transmission path for SARS-CoV-2. In this investigation, models of other researchers which had the aim of predicting an infection risk for exposed persons in a room through aerosols emitted by an infectious case-patient were extended. As a novelty – usually neglected – parameters or boundary conditions, namely the non COLCHICINE IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19 Background Colchicine has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory actions. Methods In this randomised, controlled, open-label trial, several possible treatments were compared with usual care in patients hospitalised with COVID-19. Eligible and consenting adults were randomly allocated in a 1:1 ratio to either usual standard of care alone or usual PATTERNS OF COVID-19 PANDEMIC DYNAMICS FOLLOWING Studies on the real-life impact of the BNT162b2 vaccine, recently authorized for the prevention of coronavirus disease 2019 (COVID-19), are urgently needed. Here, we analysed the temporal dynamics of the number of new COVID-19 cases and hospitalization in Israel following a vaccination campaign initiated on December 20th, 2020. We conducted a retrospective analysis of data originating EFFECTIVENESS OF BNT162B2 MRNA VACCINE AND CHADOX1 We estimated risk of death in vaccinated compared to unvaccinated COVID-19 cases. Cases vaccinated with 1 dose of BNT162b2 had 44% reduced risk of death, 55% with 1 dose of ChAdOx1, and 69% with 2 doses of BNT162b2. This is on top of the protection provided against becoming a case. ### Competing Interest Statement The authors have declared no competing interest. CHARACTERIZATION OF THE EMERGING B.1.621 VARIANT OF SARS-CoV-2 genetic diversity has the potential to impact the virus transmissibility and the escape from natural infection- or vaccine-elicited neutralizing antibodies. Here, we report the emergence of the B.1.621 lineage, considered a variant of interest (VOI) with the accumulation of several mutations affecting the Spike protein, including the amino acid changes I95I, Y144T, Y145S and the A QUANTITATIVE RISK-BENEFIT ANALYSIS OF CHADOX1 NCOV-19 ChAdOx1 nCoV-19 is a vaccine against the COVID-19 infection that was granted a conditional marketing authorization by the European Commission in January 2021. However, following a report from the Pharmacovigilance Risk Assessment Committee (PRAC) of European Medicines Agency, which reported an association with thrombo-embolic events (TEE), in particular Disseminated ADVANCING THE SHARING OF RESEARCH RESULTS FOR THE HEALTH medRxiv - The Preprint Server for Health Sciences. medRxiv (pronounced "med-archive") is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminaryreports of
VACCINE EFFECTIVENESS OF THE FIRST DOSE OF CHADOX1 NCOV-19 Background The effectiveness of SARS-CoV-2 vaccines in frail older adults living in Long-Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of ChAdOx1 and BNT162b2 vaccines against infection in this population. Methods Cohort study comparing vaccinated and unvaccinated LTCF residents in England, undergoing routine asymptomatic testing (8 RAPID DETECTION OF NEUTRALIZING ANTIBODIES TO SARS-COV-2 Results Establishment of a modified hiVNT for qualitative detection of SARS-CoV-2 nAb Using the spikes of the prototype virus (D614G) and seven variants (B.1.1.7, B.1.351, P.1, SUBMIT YOUR ARTICLE TO MEDRXIV, AN ONLINE ARCHIVE AND medRxiv (pronounced "med-archive") is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news ANTI-SPIKE PROTEIN ASSAYS TO DETERMINE POST-VACCINATION Background Reliable quantification of the antibody response to SARS-CoV-2 vaccination is highly relevant for identifying possible vaccine failure and estimating the time of protection. Therefore, we aimed to evaluate the performance of five different Anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies induced after a single dose of BNT162b2.MEDRXIV.ORG
medRxiv.org - the preprint server for Health Sciences. Advanced Search. Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should THERAPEUTIC ANTICOAGULATION IN CRITICALLY ILL PATIENTS Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. Methods We conducted an open-label, adaptive, multiplatform, randomized, clinical trial. Patients with severe Covid-19, defined as the requirement for organ support with high flow nasal cannula, non FDA-AUTHORIZED COVID-19 VACCINES ARE EFFECTIVE PER REAL Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively. Given the ongoing vaccine rollout to healthcare personnel and residents of long-term care facilities, EVIDENCE FOR INCREASED BREAKTHROUGH RATES OF SARS-COV-2 The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but SPIKE PROTEIN ANTIBODIES MEDIATE THE APPARENT CORRELATION Objectives SARS-CoV-2 infection induces the formation of different antibodies. However, not all of which might prevent the virus from entering the cell, although their concentrations correlate with the titers of viral neutralization tests (NTs). Antibodies against the viral nucleocapsid (NC), e.g., can be classified as such. We aimed to prove the hypothesis that the apparent correlation CHARACTERIZATION OF THE SECOND WAVE OF COVID-19 IN INDIA Second Wave of COVID-19 in India 3 (a) Daily cases. (b) Daily deaths. Fig. 1: Comparison of COVID-19 spread in India with ve other severely-a ected countries. SHUT AND RE-OPEN: THE ROLE OF SCHOOLS IN THE SPREAD OF We investigate the effect of school closure and subsequent reopening on the transmission of COVID-19, by considering Denmark, Norway, Sweden, and German states as case studies. By comparing the growth rates in daily hospitalisations or confirmed cases under different interventions, we provide evidence that the effect of school closure is visible as a reduction in the growth rate REAL-WORLD EFFECTIVENESS OF AD26.COV2.S ADENOVIRAL VECTOR Clinical trials have demonstrated that multiple COVID-19 vaccines, including Ad26.COV2.S, are highly efficacious in reducing the risk ofsevere illness.
PHYSICAL, COGNITIVE AND MENTAL HEALTH IMPACTS OF COVID-19 2 Background The impact of COVID-19 on physical and mental health, and employment following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, observational study of adults discharged from hospital PREDICTED INFECTION RISK FOR AEROSOL TRANSMISSION OF SARS Currently, the respiratory route is seen as the most important transmission path for SARS-CoV-2. In this investigation, models of other researchers which had the aim of predicting an infection risk for exposed persons in a room through aerosols emitted by an infectious case-patient were extended. As a novelty – usually neglected – parameters or boundary conditions, namely the nonMEDRXIV.ORG
medRxiv.org - the preprint server for Health Sciences. Advanced Search. Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should THERAPEUTIC ANTICOAGULATION IN CRITICALLY ILL PATIENTS Background Thrombosis may contribute to morbidity and mortality in Covid-19. We hypothesized that therapeutic anticoagulation would improve outcomes in critically ill patients with Covid-19. Methods We conducted an open-label, adaptive, multiplatform, randomized, clinical trial. Patients with severe Covid-19, defined as the requirement for organ support with high flow nasal cannula, non FDA-AUTHORIZED COVID-19 VACCINES ARE EFFECTIVE PER REAL Large Phase 3 clinical trials of the two FDA-authorized COVID-19 vaccines, mRNA-1273 (Moderna) and BNT162b2 (Pfizer/BioNTech), have demonstrated efficacies of 94.1% (n = 30,420, 95% CI: 89.3-96.8) and 95% (n = 43,448, 95% CI: 90.3-97.6) in preventing symptomatic COVID-19, respectively. Given the ongoing vaccine rollout to healthcare personnel and residents of long-term care facilities, EVIDENCE FOR INCREASED BREAKTHROUGH RATES OF SARS-COV-2 The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but SPIKE PROTEIN ANTIBODIES MEDIATE THE APPARENT CORRELATION Objectives SARS-CoV-2 infection induces the formation of different antibodies. However, not all of which might prevent the virus from entering the cell, although their concentrations correlate with the titers of viral neutralization tests (NTs). Antibodies against the viral nucleocapsid (NC), e.g., can be classified as such. We aimed to prove the hypothesis that the apparent correlation CHARACTERIZATION OF THE SECOND WAVE OF COVID-19 IN INDIA Second Wave of COVID-19 in India 3 (a) Daily cases. (b) Daily deaths. Fig. 1: Comparison of COVID-19 spread in India with ve other severely-a ected countries. SHUT AND RE-OPEN: THE ROLE OF SCHOOLS IN THE SPREAD OF We investigate the effect of school closure and subsequent reopening on the transmission of COVID-19, by considering Denmark, Norway, Sweden, and German states as case studies. By comparing the growth rates in daily hospitalisations or confirmed cases under different interventions, we provide evidence that the effect of school closure is visible as a reduction in the growth rate REAL-WORLD EFFECTIVENESS OF AD26.COV2.S ADENOVIRAL VECTOR Clinical trials have demonstrated that multiple COVID-19 vaccines, including Ad26.COV2.S, are highly efficacious in reducing the risk ofsevere illness.
PHYSICAL, COGNITIVE AND MENTAL HEALTH IMPACTS OF COVID-19 2 Background The impact of COVID-19 on physical and mental health, and employment following hospitalisation is poorly understood. Methods PHOSP-COVID is a multi-centre, UK, observational study of adults discharged from hospital PREDICTED INFECTION RISK FOR AEROSOL TRANSMISSION OF SARS Currently, the respiratory route is seen as the most important transmission path for SARS-CoV-2. In this investigation, models of other researchers which had the aim of predicting an infection risk for exposed persons in a room through aerosols emitted by an infectious case-patient were extended. As a novelty – usually neglected – parameters or boundary conditions, namely the non COLCHICINE IN PATIENTS ADMITTED TO HOSPITAL WITH COVID-19 Background Colchicine has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory actions. Methods In this randomised, controlled, open-label trial, several possible treatments were compared with usual care in patients hospitalised with COVID-19. Eligible and consenting adults were randomly allocated in a 1:1 ratio to either usual standard of care alone or usual PATTERNS OF COVID-19 PANDEMIC DYNAMICS FOLLOWING Studies on the real-life impact of the BNT162b2 vaccine, recently authorized for the prevention of coronavirus disease 2019 (COVID-19), are urgently needed. Here, we analysed the temporal dynamics of the number of new COVID-19 cases and hospitalization in Israel following a vaccination campaign initiated on December 20th, 2020. We conducted a retrospective analysis of data originating EFFECTIVENESS OF BNT162B2 MRNA VACCINE AND CHADOX1 We estimated risk of death in vaccinated compared to unvaccinated COVID-19 cases. Cases vaccinated with 1 dose of BNT162b2 had 44% reduced risk of death, 55% with 1 dose of ChAdOx1, and 69% with 2 doses of BNT162b2. This is on top of the protection provided against becoming a case. ### Competing Interest Statement The authors have declared no competing interest. CHARACTERIZATION OF THE EMERGING B.1.621 VARIANT OF SARS-CoV-2 genetic diversity has the potential to impact the virus transmissibility and the escape from natural infection- or vaccine-elicited neutralizing antibodies. Here, we report the emergence of the B.1.621 lineage, considered a variant of interest (VOI) with the accumulation of several mutations affecting the Spike protein, including the amino acid changes I95I, Y144T, Y145S and the A QUANTITATIVE RISK-BENEFIT ANALYSIS OF CHADOX1 NCOV-19 ChAdOx1 nCoV-19 is a vaccine against the COVID-19 infection that was granted a conditional marketing authorization by the European Commission in January 2021. However, following a report from the Pharmacovigilance Risk Assessment Committee (PRAC) of European Medicines Agency, which reported an association with thrombo-embolic events (TEE), in particular Disseminated ADVANCING THE SHARING OF RESEARCH RESULTS FOR THE HEALTH medRxiv - The Preprint Server for Health Sciences. medRxiv (pronounced "med-archive") is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminaryreports of
VACCINE EFFECTIVENESS OF THE FIRST DOSE OF CHADOX1 NCOV-19 Background The effectiveness of SARS-CoV-2 vaccines in frail older adults living in Long-Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of ChAdOx1 and BNT162b2 vaccines against infection in this population. Methods Cohort study comparing vaccinated and unvaccinated LTCF residents in England, undergoing routine asymptomatic testing (8 RAPID DETECTION OF NEUTRALIZING ANTIBODIES TO SARS-COV-2 Results Establishment of a modified hiVNT for qualitative detection of SARS-CoV-2 nAb Using the spikes of the prototype virus (D614G) and seven variants (B.1.1.7, B.1.351, P.1, SUBMIT YOUR ARTICLE TO MEDRXIV, AN ONLINE ARCHIVE AND medRxiv (pronounced "med-archive") is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news ANTI-SPIKE PROTEIN ASSAYS TO DETERMINE POST-VACCINATION Background Reliable quantification of the antibody response to SARS-CoV-2 vaccination is highly relevant for identifying possible vaccine failure and estimating the time of protection. Therefore, we aimed to evaluate the performance of five different Anti-SARS-CoV-2 antibody assays regarding the quantification of anti-spike (S) antibodies induced after a single dose of BNT162b2. Skip to main content* Home
* About
* Submit
* ALERTS / RSS
Search for this keyword__
Advanced Search
Caution: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxivSUBJECT AREAS
ALL ARTICLES
*
Addiction Medicine
*
Allergy and Immunology*
Anesthesia
*
Cardiovascular Medicine*
Dentistry and Oral Medicine*
Dermatology
*
Emergency Medicine
*
Endocrinology (including Diabetes Mellitus and Metabolic Disease)*
Epidemiology
*
Forensic Medicine
*
Gastroenterology
*
Genetic and Genomic Medicine*
Geriatric Medicine
*
Health Economics
*
Health Informatics
*
Health Policy
*
Health Systems and Quality Improvement*
Hematology
*
HIV/AIDS
*
Infectious Diseases (except HIV/AIDS)*
Intensive Care and Critical Care Medicine*
Medical Education
*
Medical Ethics
*
Nephrology
*
Neurology
*
Nursing
*
Nutrition
*
Obstetrics and Gynecology*
Occupational and Environmental Health*
Oncology
*
Ophthalmology
*
Orthopedics
*
Otolaryngology
*
Pain Medicine
*
Pain Medicine
*
Palliative Medicine
*
Pathology
*
Pediatrics
*
Pharmacology and Therapeutics*
Primary Care Research*
Psychiatry and Clinical Psychology*
Public and Global Health*
Radiology and Imaging*
Rehabilitation Medicine and Physical Therapy*
Respiratory Medicine*
Rheumatology
*
Sexual and Reproductive Health*
Sports Medicine
*
Surgery
*
Toxicology
*
Transplantation
*
Urology
View by Month
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us toset cookies.
Continue Find out moreDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0